Global Human Microbiome Market

Human Microbiome Market To Witness Exponential Growth With USD 1,597 Mn Earnings By 2028

Market growth is largely driven by the increasing focus on the development of human microbiome therapy. It has also become a validated target for drug development. The growing number of collaborations between market players is also expected to offer a wide range of growth opportunities for market players during the forecast period. However, a lack of expertise and inadequate research on the human microbiome are factors expected to restrain this market’s growth.

The human microbiome market is projected to reach USD 1,598 million by 2028 from USD 894 million in 2025, at a CAGR of 21.3% from 2025 to 2028.

Driver: Increasing focus on human microbiome therapeutics development

Human gut microbiomes play a major role in improving the efficacy of therapeutic compounds. Over the years, studies have shown that the right combination of microbes in the human body is beneficial for treating different conditions. This association between microbes and specific disease states could generate new opportunities for drug developers (or vaccine manufacturers). Microbes are rich sources of enzymes, owing to which they can be used in various therapeutic applications, such as the search for novel therapies.

Global Human Microbiome Market
Global Human Microbiome Market

In the last decade, microbiome therapy has gained widespread importance. During a 10-year timespan (fiscal years 2007–2016), the National Institutes of Health (NIH) invested USD 215 million on the Human Microbiome Project (HMP) and USD 728 million on extramural human microbiome research activities outside of the HMP over fiscal years 2012–2016. Similarly, the European Commission established Metagenomics of the Human Intestinal Tract project (MetaHIT), which is mainly focused on gut bacteria. From 2008 to 2012, ~USD 15 million was invested in this project. From 2012 to 2018 ~USD 14 million (EUR 12 million) was invested in MetaCardis (Metagenomics in Cardiometabolic Diseases), which is a major EU-funded research project that investigated the role of gut microbes in cardiometabolic diseases (CMDs). Similarly, Horizon 2020 is one of the biggest EU Research and Innovation programs with funding of nearly USD 96.9 million (€80 billion) available over seven years (2014 to 2020).

Read Also:  Global Point-of-Use Water Treatment Systems Market 2022 - Corporate Financial Plan, Business Competitors, Manufacturers,Supply and Revenue

It also offers an exclusive insight into various details such as revenues, market share, strategies, growth rate, product & their pricing by region/country for all major companies.

The Report Lists the Key Companies in the Human Microbiome Market:

Rebiotix, Inc., uBiome, Inc., Osel, Inc., Enterome Biosciences, OBiome LLC, Vedanta Biosciences, Seres Therapeutics, Second Genome, Metabiomics Corp., and Synthetic Biologics, Inc.

The report provides a 360-degree overview of the market, listing various factors restricting, propelling, and obstructing the market in the forecast duration. The report also provides additional information such as interesting insights, key industry developments, detailed segmentation of the market, list of prominent players operating in the market, and other Human Microbiome market trends. The report is available for sale on the company website.

Further, the report acknowledges that in these growing and promptly enhancing market circumstances, the most recent advertising and marketing details are very important to determine the performance in the forecast period and make essential choices for profitability and growth of the Human Microbiome. In addition, the report encompasses an array of factors that impact the growth of the Human Microbiome in the forecast period. Further, this specific analysis also determines the impact on the individual segments of the market.

Product Types: Probiotics, Prebiotics, Medical Foods, And Supplements

On the Basis of Application: Therapeutics And Diagnostics

FREE : Request Sample is Available @ https://www.zionmarketresearch.com/sample/human-microbiome-market

Regional Analysis for Human Microbiome Market :

  • North America (the USA and Canada)
  • Europe (UK, Germany, France, Italy, Spain, Scandinavia and Rest of Europe)
  • Asia Pacific (Japan, China, India, Australia, Southeast Asia and Rest of Asia Pacific)
  • Latin America (Brazil, Mexico and Rest of Latin America)
  • Middle East & Africa (South Africa, GCC and Rest of the Middle East & Africa)
Read Also:  Global Computer Power Cable Assemblies Market Top Industry Players Outlook 2022-2030: Alpha Wire, TE Connectivity, RS Pro, Switchcraft, Tripp Lite

Major Table of Contents for Human Microbiome Market :

1.Introduction

2.Executive Summary

3.Market Dynamics

4.Key Human Microbiome Market Insights

5.Global Market Analysis, Insights and Forecast, 2015-2027

6.North America Market Analysis, Insights and Forecast, 2015-2027

7.Europe Market Analysis, Insights and Forecast, 2015-2027

8.Asia Pacific Market Analysis, Insights and Forecast, 2015-2027

9.The Middle East and Africa Market Analysis, Insights and Forecast, 2015-2027

10.Latin America Market Analysis, Insights and Forecast, 2015-2027

11.Competitive Landscape

12.Global Human Microbiome Market Revenue Share Analysis, By Key Players, 2021

13.Company Profiles

14.Conclusion

Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Europe or Asia.